Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study (Q46404384)

21 December 2017

title

Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study (English)

1 reference

21 December 2017

0 references

9

Hilkka Soininen

1 reference

PubMed ID

23676340

Mikael von und zu Fraunberg

21 December 2017

3

object named as

Mikael Fraunberg

1 reference

21 December 2017

Ilona Hallikainen

1

1 reference

21 December 2017

Tuomo Hänninen

2

1 reference

21 December 2017

Kristiina Hongisto

4

1 reference

21 December 2017

Tarja Välimäki

5

1 reference

21 December 2017

Asta Hiltunen

6

1 reference

21 December 2017

Pertti Karppi

7

1 reference

21 December 2017

Juhani Sivenius

8

1 reference

21 December 2017

Anne M Koivisto

10

1 reference

21 December 2017

ALSOVA study group

11

1 reference

21 December 2017

publication date

16 May 2013

1 reference

21 December 2017

International Psychogeriatrics

published in

1 reference

21 December 2017

volume

25

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

1335-1344

1 reference

21 December 2017

A total score for the CERAD neuropsychological battery.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Caregiver depression is associated with a low sense of coherence and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Relationship between cognitive impairment and behavioural disturbances in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Assessment of potential measures in models of progression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

The existence of cognitive plateaus in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

Cholinesterase inhibitors for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000653

7 January 2021

10.1017/S1041610213000653

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

23676340

1 reference

21 December 2017